HSBC Holdings
BBIO icon

HSBC Holdings’s BridgeBio Pharma BBIO Stock Holding History

HSBC Holdings’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,708
Closed -$2.43M – 2941
2026
Q1 		$2.43M Buy
32,708
+19,043
+139% +$1.38M ﹤0.01% 1437
2025
Q4 		$1.05M Buy
+13,665
New +$897K ﹤0.01% 1911
2025
Q3 		– Sell
-6,292
Closed -$271K – 2727
2025
Q2 		$271K Sell
6,292
-9,999
-61% -$364K ﹤0.01% 2518
2025
Q1 		$557K Sell
16,291
-11,957
-42% -$403K ﹤0.01% 2021
2024
Q4 		$784K Buy
28,248
+4,646
+20% +$120K ﹤0.01% 1932
2024
Q3 		$603K Buy
+23,602
New +$620K ﹤0.01% 1917
2024
Q2 		– Sell
-11,849
Closed -$366K – 2946
2024
Q1 		$366K Buy
+11,849
New +$403K ﹤0.01% 2287
2023
Q1 		– Sell
-43,184
Closed -$317K – 2687
2022
Q4 		$317K Sell
43,184
-611
-1% -$5.85K ﹤0.01% 2516
2022
Q3 		$456K Buy
43,795
+6,509
+17% +$67.6K ﹤0.01% 2216
2022
Q2 		$338K Buy
37,286
+9,304
+33% +$77.8K ﹤0.01% 2570
2022
Q1 		$288K Buy
+27,982
New +$287K ﹤0.01% 2775
2021
Q4 		– Sell
-21,899
Closed -$1.06M – 3252
2021
Q3 		$1.06M Buy
21,899
+17,655
+416% +$946K ﹤0.01% 1849
2021
Q2 		$261K Sell
4,244
-1,144
-21% -$65.3K ﹤0.01% 2604
2021
Q1 		$329K Sell
5,388
-3,369
-38% -$220K ﹤0.01% 2230
2020
Q4 		$619K Buy
+8,757
New +$422K ﹤0.01% 2038

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

HSBC Holdings's BBIO Position: Q2 2026 in Review

HSBC Holdings sold out of BridgeBio Pharma (BBIO) in Q2 2026, closing a stake of 32,708 shares — an estimated $2.43M sold.

HSBC Holdings first reported a position in BBIO in Q4 2020 and held it in 15 quarters. The position peaked at $2.43M in Q1 2026. 475 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • HSBC Holdings reported no remaining BridgeBio Pharma position as of Q2 2026 after selling out during the quarter.
  • HSBC Holdings sold 32,708 BridgeBio Pharma shares in Q2 2026, an estimated $2.43M.
  • HSBC Holdings first reported a position in BridgeBio Pharma in Q4 2020 and held it in 15 quarters.
  • HSBC Holdings's BridgeBio Pharma position peaked at $2.43M in Q1 2026.
  • 475 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.